New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers take aim at circadian clock in deadly brain cancer

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg
Oncology June 08,2024
Researchers take aim at circadian clock in deadly brain cancer

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg
Oncology June 08,2024
Researchers criticize study calling for expansion of genetic testing for breast cancer

Researchers criticize study calling for expansion of genetic testing for breast cancer

by University of CambridgeMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaResearchers at the Unive
Oncology June 08,2024
Researchers criticize study calling for expansion of genetic testing for breast cancer

Researchers criticize study calling for expansion of genetic testing for breast cancer

by University of CambridgeMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaResearchers at the Unive
Oncology June 08,2024
Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the
Oncology June 08,2024
Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the
Oncology June 08,2024
Researchers determine epigenetic origin of docetaxel-resistant breast cancer

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me
Oncology June 08,2024
Researchers determine epigenetic origin of docetaxel-resistant breast cancer

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me
Oncology June 08,2024
Researchers describe a new resistance mechanism

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor
Oncology June 08,2024
Researchers describe a new resistance mechanism

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor
Oncology June 08,2024
Researchers describe a molecular strategy that helps prevent tumour formation in mice

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—
Oncology June 08,2024
Researchers describe a molecular strategy that helps prevent tumour formation in mice

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—
Oncology June 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com